WC
PRAX icon

Wexford Capital’s Praxis Precision Medicines PRAX Stock Holding History

Wexford Capital’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$670K Buy
+2,000
New +$633K 0.09% 83

Other funds holding PRAX

JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Wexford Capital's PRAX Position: Q2 2026 in Review

Wexford Capital opened a new position in Praxis Precision Medicines (PRAX) in Q2 2026: 2,000 shares worth $670K. The stake represents 0.09% of the portfolio and ranks #83 among its holdings.

309 funds tracked by Wall St. Rank hold PRAX as of Q2 2026.

  • Wexford Capital held 2,000 shares of Praxis Precision Medicines worth $670K as of Q2 2026.
  • Praxis Precision Medicines was a new Wexford Capital position in Q2 2026.
  • Praxis Precision Medicines made up 0.09% of Wexford Capital's portfolio in Q2 2026, its #83 holding.
  • 309 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2026.

Based on Wexford Capital's 13F filing for Q2 2026, filed 14 Aug 2026.